World Journal of Laparoscopic Surgery

Register      Login

VOLUME 10 , ISSUE 3 ( September-December, 2017 ) > List of Articles

REVIEW ARTICLE

Achalasia Cardia: Revisited

Balachandran Premkumar

Citation Information : Premkumar B. Achalasia Cardia: Revisited. World J Lap Surg 2017; 10 (3):112-116.

DOI: 10.5005/jp-journals-10033-1318

License: CC BY-NC 4.0

Published Online: 01-06-2017

Copyright Statement:  Copyright © 2017; The Author(s).


Abstract

Introduction: Achalasia cardia is a very common esophageal motility disorder affecting a large population worldwide including the Indian subcontinent. The diagnosis of the condition is equally important as the treatment ranges from medicines to botulinum injection, to pneumatic dilatation and surgery. This study gives an overview of achalasia cardia and the modalities to diagnose and treat the condition.


PDF Share
  1. Richter JE. Achalasia – an update. J Neurogastroenterol Motil 2010 Jul;16(3):232-242.
  2. Abdi S, Forotan M, Nikzamir A, Zomorody S, Jahani- Sherafat S. The early efficacy of Heller myotomy in the treatment of Iranian patients with achalasia. Gastroenterol Hepatol Bed Bench 2016 Winter;9(1):30-35.
  3. Fregnani JH, Macea JR, Barros MD, Liquidato BM, Macea MI, Alves AL, Pereira CS, Pinto AC, de Carvalho MF, Carillo J. Cardia: at the end of the day, what is it? Int J Morphol 2007 Jun;25(2):375-380.
  4. Pohl D, Tutuian R. Achalasia: an overview of diagnosis and treatment. J Gastrointestinal Liver Dis 2007 Sep;16(3):297-303.
  5. Dekel R, Martinez-Hawthorne SD, Guillen RJ, Fass R. Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain. J Clin Gastroenterol 2004 Jan;38(1):24-29.
  6. Palmer JB, Drennan JC, Baba M. Evaluation and treatment of swallowing impairments. Am Fam Physician 2000 Apr;61(8):2453-2462.
  7. Ates F, Vaezi MF. The pathogenesis and management of achalasia: current status and future directions. Gut Liver 2017 Jul;9(4):449-463.
  8. Spiess AE, Kahrilas PJ. Treating achalasia from whalebone to laparoscope. JAMA 1998 Aug;280(7):638-642.
  9. de Oliveira JM, Birgisson S, Doinoff C, Einstein D, Herts B, Davros W, Obuchowski N, Koehler RE, Richter J, Baker ME. Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol 1997 Aug;169(2):473-479.
  10. Farrokhi F, Vaezi MF. Idiopathic (primary) achalasia. Orphanet J Rare Dis 2007 Sep;2:38.
  11. Kessing BF, Smout AJ, Bredenoord AJ. Clinical applications of esophageal impedance monitoring and high-resolution manometry. Curr Gastroenterol Rep 2012 Jun;14(3):197-205.
  12. Gold, BD. Achalasia. Clinical Advisor. Available from: http://www.clinicaladvisor.com/pediatrics/achalasia/article/624740/.
  13. Gelfond M, Rozen P, Gilat T. Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation. Gastroenterology 1982 Nov;83(5): 963-969.
  14. Bortolotti M, Coccia G, Brunelli F, Sarti P, Mazza M, Bagnato F, Barbara L. Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia? Ital J Gastroenterol 1994 Oct-Nov;26(8):379-382.
  15. Smith CD, Stival A, Howell DL, Swafford V. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than Heller myotomy alone. Ann Surg 2006 May;243(5):579-584, discussion 584-586.
  16. Dughera L, Battaglia E, Maggio D, Cassolino P, Mioli PR, Morelli A, Emanuelli G, Bassotti G. Botulinum toxin treatment of oesophageal achalasia in the old old and oldest old: a 1-year follow-up study. Drugs Aging 2005 Sep;22(9):779-783.
  17. Gideon RM, Castell DO, Yarze J. Prospective randomized comparison of pneumatic dilatation technique in patients with idiopathic achalasia. Dig Dis Sci 1999 Sep;44(9):1853-1857.
  18. Chuah S-K, Wu K-L, Hu T-H, Tai W-C, Changchien C-S. Endoscope-guided pneumatic dilation for treatment of esophageal achalasia. World J Gastroenterol 2010 Jan;16(4):411-417.
  19. Eckardt VF, Kanzler G, Westermeier T. Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointest Endosc 1997 May;45(5):349-353.
  20. Wang L, Li YM, Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci 2009 Nov;54(11):2303-2311.
  21. Campos GM, Vittinghoff E, Rabl C, Takata M, Gadenstätter M, Lin F, Ciovica R. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg 2009 Jan;249(1):45-57.
  22. Rosemurgy A, Villadolid D, Thometz D, Kalipersad C, Rakita S, Albrink M, Johnson M, Boyce W. Laparoscopic Heller myotomy provides durable relief from achalasia and salvages failures after botox or dilation. Ann Surg 2005 May;241(5):725-733, discussion 733-735.
  23. Ancona E, Anselmino M, Zaninotto G, Costantini M, Rossi M, Bonavina L, Boccu C, Buin F, Peracchia A. Esophageal achalasia: laparoscopic versus conventional open Heller-Dor operation. Am J Surg 1995 Sep;170(3):265-270.
  24. Yamamura MS, Gilster JC, Myers BS, Deveney CW, Sheppard BC. Laparoscopic Heller myotomy and anterior fundoplication for achalasia results in a high degree of patient satisfaction. Arch Surg 2000 Aug;135(8):902-906.
  25. Katada N, Sakuramoto S, Kobayashi N, Futawatari N, Kuroyama S, Kikuchi S, Watanabe M. Laparoscopic Heller myotomy with Toupet fundoplication for achalasia straightens the esophagus and relieves dysphagia. Am J Surg 2006 Jul;192(1):1-8.
  26. Rossetti G, Brusciano L, Amato G, Maffettone V, Napolitano V, Russo G, Izzo D, Russo F, Pizza F, Genio GD, et al. A total fundoplication is not an obstacle to esophageal emptying after Heller myotomy for achalasia: results of a long-term follow up. Ann Surg 2005 Apr;241(4):614-621.
  27. Roberts KE, Duffy AJ, Bell RL. Controversies in the treatment of gastroesophageal reflux and achalasia. World J Gastroenterol 2006 May;12(20):3155-3161.
  28. Khajanchee YS, Kanneganti S, Leatherwood AE, Hansen PD, Swanström LL. Laparoscopic Heller myotomy with Toupet fundoplication. Arch Surg 2005 Sep;140(9):827-834.
  29. Richards WO, Torquati A, Holzman MD, Khaitan L, Byrne D, Lutfi R, Sharp KW. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia. Ann Surg 2004 Sep;240(3):405-415.
  30. Horgan S, Galvani C, Gorodner MV, Omelanczuck P, Elli F, Moser F, Durand L, Caracoche M, Nefa J, Bustos S, et al. Robotic-assisted Heller myotomy versus laparoscopic Heller myotomy for the treatment of esophageal. J Gastrointest Surg 2005 Nov;9(8):1020-1030.
  31. Ling TS, Guo HM, Yang T, Peng CY, Zou XP, Shi RH. Effectiveness of peroral endoscopic myotomy in the treatment of achalasia: a pilot trial in Chinese Han population with a minimum of one-year follow-up. J Dig Dis 2014 Jul;15(7): 352-358.
  32. Dughera L, Chiaverina M, Cacciotella L, Cisarò F. Management of achalasia. Clin Exp Gastroenterol 2011 Feb;4: 33-41.
  33. Leeuwenburgh I, Scholten P, Caljé TJ, Vaessen RJ, Tilanus HW, Hansen BE, Kuipers EJ. Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia. Dig Dis Sci 2013 Jan;58(1):244-252.
  34. Colombo JR Jr, Haber GP, Rubinstein M, Gill IS. Laparoscopic surgery in urological oncology: brief overview. Int Braz J Urol 2006 Sep-Oct;32(5):504-512.
  35. Shimokihara K, Kawahara T, Takamoto D, Mochizuki T, Hattori Y, Teranishi J-i, Miyoshi Y, Chiba S, Uemura H. Port site recurrence after laparoscopic radical nephrectomy. J Med Case Rep 2017 Jun;11(1):151.
  36. Huang J, Lin T, Liu H, Xu K, Zhang C, Jiang C, Huang H, Yao Y, Guo Z, Xie W. Laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer: oncologic results of 171 cases with a median 3-year follow-up. Eur Urol 2010 Sep;58(3):442-449.
  37. Spermon JR, Witjes JA. Case report: the danger of postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma. J Endourol 2008 May;22(5):1013-1016.
  38. Masterson TA, Russo P. A case of port-site recurrence and locoregional metastasis after laparoscopic partial nephrectomy. Nat Clin Pract Urol 2008 Jun;5(6):345-349.
  39. Segawa N, Azuma H, Takahara K, Hamada S, Kotake Y, Tsuji M, Katsuokai Y. [Port-site metastasis after retroperitoneoscopy-assisted nephroureterectomy and cystectomy for bladder cancer invading the ureter: a case report]. Hinyokika Kiyo 2008 Jan;54(1):13-16.
  40. Cresswell J, Scheitlin W, Grozen A, Lenz E, Teber D, Rassweiler J. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience. Br J Urol Int 2008;102:844-848.
  41. Castillo OA, Vitagliano G, Díaz M, Sánchez-Salas R. Port-site metastasis after laparoscopic partial nephrectomy: case report and literature review. J Endourol 2007 Apr;21(4): 404-407.
  42. Muntener M, Nielsen ME, Romero FR, Schaeffer EM, Allaf ME, Brito FA, Pavlovich CP, Kavoussi LR, Jarrett TW. Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma. Eur Urol 2007 Jun;51(6):1639-1644.
  43. Manabe D, Saika T, Ebara S, Uehara S, Nagai A, Fujita R, Irie S, Yamada D, Tsushima T, Nasu Y, et al.; Okayama Urological Research Group, Okayama, Japan. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology 2007 Mar;69(3):457-461.
  44. Dhobada S, Patankar S, Gorde V. Port-site metastasis after laparoscopic radical nephrectomy for renal-cell carcinoma: case report. J Endourol 2006 Feb;20(2):119-122.
  45. Kobori Y, Shigehara K, Amano T, Takemae K. [Port site metastasis of primary adenocarcinoma of the renal pelvis after a laparoscopic nephrectomy: a case report]. Hinyokika Kiyo 2005 Feb;51(2):105-108.
  46. El-Tabey NA, Shoma AM. Port site metastases after robot assisted laparoscopic radical cystectomy. Urology 2005 Nov;66(5):1110.
  47. Porpiglia F, Fiori C, Bovio S, Destefanis P, Alì A, Terrone C, Fontana D, Scarpa RM, Tempia A, Terzolo M. Bilateral adrenalectomy for Cushing's syndrome: a comparison between laparoscopy and open surgery. J Endocrinol Invest 2004 Jul-Aug;27(7):654-658.
  48. Chueh S-CJ, Tsaia I-D, Laia M-K. Solitary port-site metastasis after laparoscopic bilateral nephroureterectomy for transitional cell carcinoma in a renal transplant recipient. Transplant Proc 2004 Nov;36(9):2697-2698.
  49. Naderi N, Nieuwenhuijzen JA, Bex A, Kooistra A, Horenblas S. Port site metastasis after laparoscopic nephro-ureterectomy for transitional cell carcinoma. Eur Urol 2004 Oct;46(4): 440-441.
  50. Iwamura M, Tsumura H, Matsuda D, Kurosaka S, Yoshida K, Baba S. Port site recurrence of renal cell carcinoma following retroperitoneoscopic radical nephrectomy with manual extraction without using entrapment sac or wound protector. J Urol 2004 Mar;171(3):1234-1235.
  51. Matsui Y, Ohara H, Ichioka K, Terada N, Yoshimura K, Terai A. Abdominal wall metastasis after retroperitoneoscopic assisted total nephroureterectomy for renal pelvic cancer. J Urol 2004 Feb;171(2 Pt 1):793.
  52. Saraiva P, Rodrigues H, Rodrigues P. Portsite recurrence after laparoscopic adrenalectomy for metastatic melanoma. Int Braz J Urol 2003 Nov-Dec;29(6):520-521.
  53. Chen YT, Yang SSD, Hsieh CH, Wang CC. Hand port-site metastasis of renal-cell carcinoma following hand-assisted laparoscopic radical nephrectomy: case report. J Endourol 2003 Nov;17(9):771-775.
  54. Wang PH, Yen MS, Juang CM, Chen YJ, Chao HT, Yuan CC. Intraperitoneal cancer spread after laparoscopic cystectomy for mature teratoma with malignant transformation. Eur J Gynaecol Oncol 2002;23(2):131-132.
  55. Castilho LN, Fugita OE, Mitre AI, Arap S. Port site tumor recurrences of renal cell carcinoma after videolaparoscopic radical nephrectomy. J Urol 2001 Feb;165(2):519.
  56. Landman J, Clayman RV. Re: port site tumor recurrences of renal cell carcinoma after videolaparoscopic radical nephrectomy (letter). J Urol 2001 Aug;166(2):629-630.
  57. Fentie DD, Barret PH, Taranger LA. Metastatic renal cell carcinoma after laparoscopic radical nephrectomy: long-term follow-up. J Endourol 2000 Jun;14(5):407-411.
  58. Otani M, Irie S, Tsuji Y. Port site metastasis after laparoscopic nephrectomy: unsuspected transitional cell carcinoma within a tuberculous atrophic kidney. J Urol 1999 Aug;162(2):486-487.
  59. Ahmed I, Shaikh NA, Kapadia CR. Track recurrence of renal pelvic transitional cell carcinoma after laparoscopic nephrectomy. Br J Urol 1998 Feb;81(2):319.
  60. Altieri V, D'Armiento M, Desio M, Ucciero G, Lotti T, Graziotti PP. Can laparoscopic lymphadenectomy disseminate bladder cancer? Acta Urol Ital 1998 Jan;12:231-233.
  61. Bangma C, Kirkels WJ, Chadha S, Schröder FH. Cutaneous metastasis following laparoscopic pelvic lymphadenectomy for prostatic carcinoma. J Urol 1995 May;153(5):1635-1636.
  62. Andersen JR, Steven K, Smith AD. Implantation metastasis after laparoscopic biopsy of bladder cancer. J Urol 1995 Mar;153(3 Pt 2):1047-1048.
  63. Maciel GA, Soares Junior (Jr), Alves Da Motta EL, Abi Haidar M, De Lima AR, Baracat EC. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin. Fertil Steril 2004;81:355-60.
  64. Kumari AS, Haq A, Jayasundaram R, Abdel-Wareth LO, Al Haija SA, Alvarez M. Metformin monotherapy in lean women with polycystic ovary syndrome. R & Pro D. Biomed Online 2005;10:100-04.
  65. Crave JC, Fimbel S, Lejeune H, Cugnardey N, Dechaud H, Pugeat M. Effects of diet and metformin administration on sex hormone binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 1995;80:2057-62.
  66. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85:2767-74.
  67. Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL, Polonsky KS. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:524-30.
  68. De Leo V, la Marca A, Ditto A, Morgante G, Cianci A. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 1999;72:282-85.
  69. Yarali H, Yildiz B, Demirol A, Zeyneloglu HB, Yigit N, Bukulmez O, Koray Z. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: A prospective randomized trial. Hum Reprod 2002;17:289-94.
  70. Palomba S, Falbo A, Orio F (Jr), Manguso F, Russo T, Tolino A, Colao A, Dale B, Zullo F. A randomized controlled trial evaluating metformin pretreatment and coadministration in nonobese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian hyperstimulation plus timed intercourse or intrauterine insemination. Hum Reprod 2005 Jun 15 (Epub ahead of print).
  71. Stadtmauer LA, Toma SK, Riehl RM, Talbert LM. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril 2001;75:505-09.
  72. Stadtmauer LA, Toma SK, Riehl RM, Talbert LM. Impact of metformin therapy on ovarian stimulation and outcome in ‘coasted’ patients with polycystic ovary syndrome undergoing in vitro fertilization. Reprod Biomed Online 2002;5:112-16.
  73. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce firsttrimester spontaneous abortion: A pilot study. Fertil Steril 2001;75:46-52.
  74. Kocak M, Caliskan E, Simsir C, Haberal A. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 2002;77:101-06.
  75. Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem 1990;33:2933-42.
  76. Akhtar M, Njar VC, Wright JN. Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes. J Steroid Biochem Mol Biol 1993;44:375-87.
  77. Palter SF, Tavares AB, Hourvitz A, Veldhuis JD, Adashi EY. Are estrogens of import to primate/human ovarian folliculogenesis? Endocr Rev 2001;22:389-424.
  78. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;84:2951-56.
  79. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622-29.
  80. Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev 1992;13:641-69.
  81. Mitwally MF, Casper RF. Aromatase inhibitors for the treatment of infertility. Expert Opin Investig Drugs 2003;12:353-71.
  82. Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 2005;192:381-86.
  83. Mitwally MFM, Casper RF. The use of aromatase inhibitor for induction of ovulation in cases of clomiphene citrate failure. Curr Opin Obstet Gynecol 2002;14:255-63.
  84. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001;75:305-09.
  85. Sammour A, Bijan MM, Tan SL, Tulandi T. Prospective randomised trial comparing the effects of letrazole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing superovulation prior to intrauterine insemination (IUI). Fertil Steril 2001;76(Suppl 1):S110.
  86. Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005;83:229-31.
  87. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002;78:280-85.
  88. Fatemi HM, Kalibianakis E, Tournaye H, Camus M, Van Steirteghem AC, Devroey P. Clomiphene citrate vs letrozole for ovarian stimulation: A pilot study. Reprod Biomed Online 2003;7:543-46.
  89. Hu Y, Cortvrindt R, Smitz J. Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture. Mol Reprod Dev 2002;61: 549-59.
  90. Shetty G, Krishnamurthy H, Krishnamurthy HN, Bhatnagar S, Moudgal NR. Effect of estrogen deprivation on the reproductive physiology of male and female primates. J Steroid Biochem Mol Biol 1997;61:157-66.
  91. Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 2003;18:1588-97.
  92. Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002;77:776-80.
  93. Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN. A randomized single blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: A preliminary report. Hum Reprod 2004;19:2031-35.
  94. Newkirk KM, Chandler HL, Parent AE, et al. Ultraviolet radiation-induced corneal degeneration in 129 mice. Toxicol Pathol 2007;35:819-26.
  95. Pettenati MJ, Sweatt AJ, Lantz P, et al. The human cornea has a high incidence of acquired chromosome abnormalities. Hum Genet 1997;101:26-29.
  96. Snibson GR. Collagen cross-linking: A new treatment paradigm in corneal disease—a review. Clin Experiment Ophthalmol 2010;38:141-53.
  97. Spoerl E, Raiskup-Wolf F, Kuhlisch E, Pillunat LE. Cigarette smoking is negatively associated with keratoconus. J Refract Surg 2008;24:S737-40.
  98. Rabinowitz YS, Nesburn AB, McDonnell PJ. Videokeratography of the fellow eye in unilateral keratoconus. Ophthalmology 1993;100:181-86.
  99. Goodrich DW, Lee WH. The molecular genetics of retinoblastoma. Cancer Surv 1990;9:529-54.
  100. Moodaley LC, Woodward EG, Liu CS, Buckley RJ. Life expectancy in keratoconus. Br J Ophthalmol 1992;76:590-91.
  101. Honein MA, Dawson AL, Petersen EE, Jones AM, Lee EH, Yazdy MM, Ahmad N, Macdonald J, Evert N, Bingham A, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 2017 Jan 3;317(1):59-68.
  102. Chervenak FA, Jeanty P, Cantraine F, Chitkara U, Venus I, Berkowitz RL, Hobbins JC. The diagnosis of fetal microcephaly. Am J Obstet Gynecol 1984 Jul 1;149(5):512-517.
  103. Papageorghiou AT, Thilaganathan B, Bilardo CM, Ngu A, Malinger G, Herrera M, Salomon LJ, Riley LE, Copel JA. ISUOG Interim Guidance on ultrasound for Zika virus infection in pregnancy: information for healthcare professionals. Ultrasound Obstet Gynecol 2016 Apr;47(4):530-532.
  104. Chibueze EC, Parsons AJ, Lopes KD, Yo T, Swa T, Nagata C, Horita N, Morisaki N, Balogun OO, Dagvadorj A, et al. Diagnostic accuracy of ultrasound scanning for prenatal microcephaly in the context of Zika virus infection: a systematic review and meta-analysis. Sci Rep 2017 May 23;7(1):2310.
  105. Cordeiro MT. Zika virus: laboratory diagnosis. In: Zika in focus. Springer International Publishing; 2017. pp. 59-62.
  106. Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodušek V, et al. Zika virus associated with microcephaly. N Engl J Med 2016 Mar 10;374(10):951-958.
  107. Zare Mehrjardi M, Keshavarz E, Poretti A, Hazin AN. Neuroimaging findings of Zika virus infection: a review article. Jpn J Radiol 2016 Dec;34(12):765-770.
  108. Oliveira Melo AS, Malinger G, Ximenes R, Szejnfeld PO, Alves Sampaio S, Bispo de Filippis AM. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol 2016 Jan;47(1):6-7.
  109. Araujo AQ, Silva MT, Araujo AP. Zika virus-associated neurological disorders: a review. Brain 2016;139(8):2122-2130.
  110. Brasil P, Pereira JP Jr, Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, Rabello RS, Valderramos SG, Halai UA, Salles TS, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 2016 Dec 15;375(24):2321-2334.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.